Clinical trial
Stem Cell Study for Patients With Heart Failure
NCT00346177 · Losordo, Douglas, M.D., Other · Withdrawn
Key facts
| NCT number | NCT00346177 |
|---|---|
| Title | Stem Cell Study for Patients With Heart Failure |
| Official title | Injection of Autologous CD34+ Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia and LVEF < 40% |
| Lead sponsor | Losordo, Douglas, M.D., Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Ischemia, Congestive Heart Failure, Cardiovascular Disease |
| Intervention type | Biological |
| Interventions | Autologous Stem Cells |
| Enrollment | 30 |
| Start date | Sep 1, 2010 |
| Primary completion | Sep 1, 2011 |
| Completion | Sep 1, 2012 |
| First posted | Jun 29, 2006 |
| Last update posted | Sep 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: